[
    [
        {
            "time": "",
            "original_text": "财信证券医药生物行业2021年8月月度报告：坚守高景气，关注高性价比个股",
            "features": {
                "keywords": [
                    "医药生物",
                    "行业报告",
                    "高景气",
                    "高性价比",
                    "个股"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "财信证券医药生物行业2021年8月月度报告：坚守高景气，关注高性价比个股",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 2
            }
        }
    ]
]